Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy ...Middle East

– Round co-led by new investors, Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio, and Boehringer Ingelheim Venture Fund – Proceeds will support the Phase 1/2 clinical trial of lead candidate, NVC-001, in patients with...

Read More Details
Finally We wish PressBee provided you with enough information of ( Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy )

Also on site :

• Emmy Predictions: Talk/Scripted Variety Series — The Variety Categories Are Still a Mess; Netflix, Dropout, and ‘Hot Ones’ Stir Up Buzz
• Ex-Bellingcat child porn researcher commits suicide after conviction for abusing own child – media
• Khloe Kardashian and Podcaster Totally Gush Over Each Other and Fans Are Swooning